Vaccine maker Adimmune Corp (國光生技) last week applied to the Food and Drug Administration (FDA) to run phase I human clinical trials of one of its COVID-19 vaccine candidates, the company said on Monday.
Last month, in the first stage of animal testing, one antigen prototype — four were designed to fight the virus based on the company’s recombinant protein technology — was found to inhibit growth of the novel coronavirus, the company said.
Although the candidate has yet to undergo full animal testing, Adimmune applied to use it in human trials under the FDA’s fast-track program for emergency use authorizations, which is intended to speed up the development of a treatment for COVID-19, it said.
The first stage of animal testing aimed to find out if mice injected with the antigen could generate antibodies strong enough to curb viral replication, while the second stage of testing aims to determine if the antigen would endanger the mice, Adimmune spokesman Pan Fei (潘飛) told the Taipei Times by telephone.
“The second stage will take six months and we just began the testing last month, so it would be too late if we waited for the outcome before moving on to human trials,” Pan added.
Adimmune hopes to start phase I human clinical trials by August, Pan said, adding that about 100 healthy volunteers are to be injected with the vaccine to see if the antigen is safe.
The protocol has not been finalized and must be approved by the FDA, he said.
The company had discussions with the regulator before submitting the application, but does not know how long the regulator’s review might take, Pan added.
If the phase I trials go smoothly, Adimmune plans to apply to run phase II human clinical trials by the end of this year, Pan said.
“We need to test the vaccine candidate’s effectiveness in double-blind phase II clinical trials. We would inject the antigen into volunteers and see if they can be infected in an environment exposed to the novel coronavirus,” he added.
However, as the outbreak is easing in Taiwan, phase II trials might need to be conducted in other countries, Pan said, adding that the firm would discuss the matter with foreign regulators.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
TRANSFORMATION: Taiwan is now home to the largest Google hardware research and development center outside of the US, thanks to the nation’s economic policies President Tsai Ing-wen (蔡英文) yesterday attended an event marking the opening of Google’s second hardware research and development (R&D) office in Taiwan, which was held at New Taipei City’s Banciao District (板橋). This signals Taiwan’s transformation into the world’s largest Google hardware research and development center outside of the US, validating the nation’s economic policy in the past eight years, she said. The “five plus two” innovative industries policy, “six core strategic industries” initiative and infrastructure projects have grown the national industry and established resilient supply chains that withstood the COVID-19 pandemic, Tsai said. Taiwan has improved investment conditions of the domestic economy
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day